{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:08:46Z","timestamp":1785553726688,"version":"3.56.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","award":["24K18895"],"award-info":[{"award-number":["24K18895"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","award":["21K07804"],"award-info":[{"award-number":["21K07804"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","award":["24K10935"],"award-info":[{"award-number":["24K10935"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24fk0410061"],"award-info":[{"award-number":["24fk0410061"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["21fk0410037"],"award-info":[{"award-number":["21fk0410037"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jtha.2025.05.002","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T11:51:37Z","timestamp":1747137097000},"page":"2461-2472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The factor (F)VIII K1693N mutation (FVIII-Nara) in a patient with moderate hemophilia A confers resistance to thrombin-catalyzed cleavage at Arg1689 involving P4\u02b9 position"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4786-8945","authenticated-orcid":false,"given":"Shoko","family":"Furukawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nemekhbayar","family":"Baatartsogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Kashiwakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Ohmori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.05.002_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V76.1.1.1","article-title":"Surface-dependent reactions of the vitamin K-dependent enzyme complexes","volume":"76","author":"Mann","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.05.002_bib2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/312330a0","article-title":"Expression of active human factor VIII from recombinant DNA clones","volume":"312","author":"Wood","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2025.05.002_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/312337a0","article-title":"Structure of human factor VIII","volume":"312","author":"Vehar","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2025.05.002_bib4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0167-4838(86)90208-6","article-title":"The size of human factor VIII heterodimers and the effects produced by thrombin","volume":"871","author":"Fay","year":"1986","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jtha.2025.05.002_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/bi00350a035","article-title":"Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity","volume":"25","author":"Eaton","year":"1986","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2025.05.002_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0268-960X(03)00025-0","article-title":"Activation of factor VIII and mechanisms of cofactor action","volume":"18","author":"Fay","year":"2004","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtha.2025.05.002_bib7","doi-asserted-by":"crossref","first-page":"8546","DOI":"10.1074\/jbc.270.15.8546","article-title":"Cleavage of factor VIII light chain is required for maximal generation of factor VIIIa activity","volume":"270","author":"Regan","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.05.002_bib8","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1074\/jbc.270.8.3648","article-title":"The role of cleavage of the light chain at positions Arg1689 or Arg1721 in subunit interaction and activation of human blood coagulation factor VIII","volume":"270","author":"Donath","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.05.002_bib9","doi-asserted-by":"crossref","first-page":"12434","DOI":"10.1074\/jbc.M009539200","article-title":"Cleavage of factor VIII heavy chain is required for the functional interaction of A2 subunit with factor IXa","volume":"276","author":"Fay","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.05.002_bib10","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1172\/JCI109209","article-title":"Immunoradiometric measurement of the factor VIII procoagulant antigen","volume":"62","author":"Lazarchick","year":"1978","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2025.05.002_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2141.1979.tb01131.x","article-title":"An immunoradiometric assay for procoagulant factor VIII antigen: results in haemophilia A, von Willebrand\u2019s disease and fetal plasma and serum","volume":"42","author":"Peake","year":"1979","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.05.002_bib12","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1073\/pnas.86.11.4277","article-title":"Direct characterization of factor VIII in plasma: detection of a mutation altering a thrombin cleavage site (arginine-372\u2014histidine)","volume":"86","author":"Arai","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2025.05.002_bib13","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood.V75.8.1664.1664","article-title":"Purification and characterization of factor VIII 372-Cys: a hypofunctional cofactor from a patient with moderately severe hemophilia A","volume":"75","author":"O\u2019Brien","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.05.002_bib14","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1182\/blood-2004-10-3939","article-title":"Thrombin-catalyzed activation of factor VIII with His substituted for Arg372 at the P1 site","volume":"105","author":"Nogami","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.05.002_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0925-5710(96)00555-5","article-title":"Anti-factor VIII inhibitor alloantibodies recognizing the A2 domain in the human factor VIII heavy chain poorly bind to porcine factor VIII","volume":"65","author":"Sawamoto","year":"1997","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtha.2025.05.002_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2257.2004.00605.x","article-title":"Usefulness of synthetic phospholipid in measurement of activated partial thromboplastin time: a new preparation procedure to reduce batch difference","volume":"26","author":"Okuda","year":"2004","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.jtha.2025.05.002_bib17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1160\/TH11-05-0331","article-title":"A putative inhibitory mechanism in the tenase complex responsible for loss of coagulation function in acquired haemophilia A patients with anti-C2 autoantibodies","volume":"107","author":"Matsumoto","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.05.002_bib18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/jth.15201","article-title":"The C-terminal acidic region in the A1 domain of factor VIII facilitates thrombin-catalyzed activation and cleavage at Arg372","volume":"19","author":"Nakajima","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.05.002_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0076-6879(93)22010-D","article-title":"Factor VIII and factor VIIIa","volume":"222","author":"Lollar","year":"1993","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.jtha.2025.05.002_bib20","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1055\/s-0041-1723996","article-title":"Acidic region residues 1680-1684 in the A3 domain of factor VIII contain a thrombin-interactive site responsible for proteolytic cleavage at Arg1689","volume":"121","author":"Nakajima","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.05.002_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jth.14621","article-title":"The 3.2 \u00c5 structure of a bioengineered variant of blood coagulation factor VIII indicates two conformations of the C2 domain","volume":"18","author":"Smith","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.05.002_bib22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2025.05.002_bib23","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3390\/biom12121764","article-title":"Boosting the full potential of PyMOL with structural biology plugins","volume":"12","author":"Rosignoli","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.jtha.2025.05.002_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/pro.3280","article-title":"Improvements to the APBS biomolecular solvation software suite","volume":"27","author":"Jurrus","year":"2018","journal-title":"Protein Sci"},{"key":"10.1016\/j.jtha.2025.05.002_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae583","article-title":"Towards the accurate modelling of antibody-antigen complexes from sequence using machine learning and information-driven docking","volume":"40","author":"Giulini","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jtha.2025.05.002_bib26","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1021\/ja026939x","article-title":"HADDOCK: a protein-protein docking approach based on biochemical or biophysical information","volume":"125","author":"Dominguez","year":"2003","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.jtha.2025.05.002_bib27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1160\/TH13-08-0690","article-title":"Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays","volume":"111","author":"Pavlova","year":"2014","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.jtha.2025.05.002_bib28","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s00277-019-03691-1","article-title":"In silico and in vitro evaluation of the impact of mutations in non-severe haemophilia A patients on assay discrepancies","volume":"98","author":"Pezeshkpoor","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtha.2025.05.002_bib29","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1182\/blood.V97.3.685","article-title":"Hemophilia A mutations associated with 1-stage\/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa","volume":"97","author":"Pipe","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.05.002_bib30","doi-asserted-by":"crossref","first-page":"9737","DOI":"10.1021\/bi700941w","article-title":"Contribution of A1 subunit residue Q316 in thrombin-activated factor VIII to A2 subunit dissociation","volume":"46","author":"Parker","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2025.05.002_bib31","doi-asserted-by":"crossref","first-page":"13246","DOI":"10.1016\/S0021-9258(18)42201-6","article-title":"Characterization of the interaction between the A2 subunit and A1\/A3-C1-C2 dimer in human factor VIIIa","volume":"267","author":"Fay","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.05.002_bib32","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1074\/jbc.271.11.6027","article-title":"Model for the factor VIIIa-dependent decay of the intrinsic factor Xase. Role of subunit dissociation and factor IXa-catalyzed proteolysis","volume":"271","author":"Fay","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.05.002_bib33","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1172\/JCI115726","article-title":"Factor VIII-East Hartford (arginine 1689 to cysteine) has procoagulant activity when separated from von Willebrand factor","volume":"89","author":"Aly","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2025.05.002_bib34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2141.1994.tb03259.x","article-title":"Abnormal factor VIII Hiroshima: defect in crucial proteolytic cleavage by thrombin at Arg1689 detected by a novel ELISA","volume":"86","author":"Kamisue","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.05.002_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031756","article-title":"The extended cleavage specificity of human thrombin","volume":"7","author":"Gallwitz","year":"2012","journal-title":"PLOS One"},{"key":"10.1016\/j.jtha.2025.05.002_bib36","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1016\/j.bmcl.2005.04.019","article-title":"A strategy to profile prime and non-prime proteolytic substrate specificity","volume":"15","author":"Petrassi","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jtha.2025.05.002_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1432-1033.1987.tb13385.x","article-title":"The effect of thrombomodulin on the cleavage of fibrinogen and fibrinogen fragments by thrombin","volume":"168","author":"Hofsteenge","year":"1987","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jtha.2025.05.002_bib38","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1021\/bi00389a004","article-title":"Identification of regions of alpha-thrombin involved in its interaction with hirudin","volume":"26","author":"Stone","year":"1987","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2025.05.002_bib39","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1073\/pnas.91.12.5518","article-title":"Molecular mapping of the heparin-binding exosite of thrombin","volume":"91","author":"Sheehan","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2025.05.002_bib40","doi-asserted-by":"crossref","first-page":"25774","DOI":"10.1074\/jbc.M002007200","article-title":"Factor VIII C2 domain contains the thrombin-binding site responsible for thrombin-catalyzed cleavage at Arg1689","volume":"275","author":"Nogami","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.05.002_bib41","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1021\/bi300070z","article-title":"P3-P3' residues flanking scissile bonds in factor VIII modulate rates of substrate cleavage and procofactor activation by thrombin","volume":"51","author":"Newell\u2013Caito","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2025.05.002_bib42","doi-asserted-by":"crossref","first-page":"27137","DOI":"10.1016\/S0021-9258(19)61490-0","article-title":"Sites in the A2 subunit involved in the interfactor VIIIa interaction","volume":"275","author":"Koszelak","year":"2000","journal-title":"J Biol Chem"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625003162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625003162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:46:00Z","timestamp":1785552360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625003162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1538783625003162"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.05.002","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The factor (F)VIII K1693N mutation (FVIII-Nara) in a patient with moderate hemophilia A confers resistance to thrombin-catalyzed cleavage at Arg1689 involving P4\u02b9 position","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}